NLGN3 interacts with Chondroitin Sulfate Proteoglycan 4 (CSPG4) on both glioma and healthy oligodendrocyte precursor cells (OPCs)6–9, facilitating CSPG4 shedding by ADAM10. Here, NLGN3 is linked to central nervous system cancer.